Rufinamide 400 mg/1

Rufinamide 400 mg tablets are an anticonvulsant medication used to manage seizures. This film-coated tablet is manufactured by Mylan Pharmaceuticals Inc. and is available in a 120-count bottle.

Rufinamide is primarily used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy. It works by stabilizing the electrical activity in the brain, helping to reduce the frequency and severity of seizures. Rufinamide 400 mg tablets are designed for oral administration and are intended for use under medical supervision.

Common effects of rufinamide may include dizziness, fatigue, and headache. Some users may also experience nausea or vomiting. These effects can vary from person to person and may subside as the body adjusts to the medication.

Rufinamide should be handled with care, stored in a cool, dry place, and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the film-coated tablets.

Rufinamide may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain CYP inhibitors may also affect the efficacy of rufinamide.